Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Boehringer Ingelheim
Merck
Baxter
Deloitte
Fuji
Daiichi Sankyo
Argus Health
McKesson

Generated: February 23, 2018

DrugPatentWatch Database Preview

COLESTID Drug Profile

« Back to Dashboard

When do Colestid patents expire, and when can generic versions of Colestid launch?

Colestid is a drug marketed by Pharmacia Upjohn and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Drug patent expirations by year for COLESTID
Pharmacology for COLESTID
Medical Subject Heading (MeSH) Categories for COLESTID

US Patents and Regulatory Information for COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-003 Sep 22, 1995 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride GRANULE;ORAL 017563-004 Sep 22, 1995 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn COLESTID colestipol hydrochloride TABLET;ORAL 020222-001 Jul 19, 1994 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for COLESTID
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 1 g ➤ Subscribe 8/23/2005

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Mallinckrodt
Covington
Cantor Fitzgerald
Chubb
McKinsey
Merck
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot